Integra Lifesciences is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical (65% of 2018 pro forma sales) and orthopedics and tissue technologies (35%). Integra earns approximately 30% of sales internationally, with the remainder derived from the United States.
| Website: | www.integralife.com |
| Email: | sravan.emany@integralife.com |
| Main Phone: | +1 609 275-0500 |
| Address: | 311 Enterprise Drive |
| State: | NJ |
| City / Town: | Plainsboro |
| Country: | USA |
| Postal Code: | 08536 |
| Exchange: | NGS |
| CEO: | Peter J. Arduini |
| Employees: | 4400 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
| Last Price 48.39 | Change $ -0.82 | Change % -1.67 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 49.20 | High 49.72 | Low 48.38 | Prev Close 49.21 |
| Last Trade | Volume 895,653 | 52 Wk Hi 67.50 | 52 Wk Low 45.96 |
| Market Cap 4.1 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 85,179,535.00 | EPS (TTM) 0.99 | PE Ratio 48.90 | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 39 | 158 |
| Number of Buys | 14 | 69 |
| Number of Sells | 25 | 89 |
| Net Activity | 5597 | 81130 |
| Last 10 Buys | Shares |
|---|---|
| Barbara B. Hill | 1,000 |
| Donald E. Morel | 1,000 |
| Donald E. Morel | 1,000 |
| Barbara B. Hill | 1,000 |
| Richard E. Caruso | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Daniel L. Reuvers | 1,000 |
| Glenn Coleman | 1,000 |
| Glenn Coleman | 1,000 |
| Joseph Vinhais | 1,000 |
| Richard E. Caruso | 1,000 |
| Richard E. Caruso | 1,000 |
| James M. Sullivan | 1,000 |
| Christian S. Schade | 1,000 |
| Keith Bradley | 1,000 |
| Jeffrey Mosebrook | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 74 | 70 | 70 | 74 |
| Low Target Price Estimate | 50 | 50 | 50 | 50 |
| Mean Target Price Estimate | 61.73 | 61.36 | 61.36 | 61.73 |
| Standard Deviation | 6.56 | 5.89 | 5.89 | 6.56 |
| Date of Most Recent Estimate | 06/01/18 | 05/22/18 | 05/22/18 | 06/01/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| SD | Specialized Disclosure Report | 5 | 2018-05-31 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 9 | 9 | 9 | 8 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 2.38 | 2.38 | 2.38 | 2.33 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
